Skip to main content
Premium Trial:

Request an Annual Quote

Emerald BioStructures, SomaLogic in DNA Aptamer Alliance

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Emerald BioStructures and SomaLogic jointly announced today that they will collaborate on the structure-based design of chemically modified DNA aptamers and small molecule therapeutics.

The alliance will combine Emerald's high-throughput X-ray crystallography expertise with SomaLogic's proprietary SOMAmer technology. The characterized DNA aptamers, called SOMAmers, will have a broad range of potential uses in the diagnostics and pharmaceutical research and development fields, the firms said.

The new alliance builds on a collaboration between the firms last year, under which they unraveled the first X-ray structure of a novel, high-value SOMAmer bound to its protein target.

"This structure allowed us to see for the first time several novel structural themes that can be achieved with SOMAmer technology, which explains the very high affinity and unique properties of our chemically modified DNA aptamers for their protein targets," Larry Gold, CEO of Boulder, Colo.-based SomaLogic said in a statement. "Our ongoing relationship with Emerald gives us the advantage of structural insight to design improved SOMAmers for both diagnostic and drug discovery applications."

Financial and other terms of the alliance were not disclosed. However, the partners said that the collaboration will support work on multiple targets.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.